Home » Topics » Regulatory » Patents

Patents
RSS

SmithKline Beecham claims new series of inhibitors of cytokine production

Feb. 15, 1999

Novel NOS inhibitors prepared at Astra, claimed for use in inflammatory disorders

Feb. 15, 1999

New compounds from Novo Nordisk for pain, inflammation, diabetes

Feb. 12, 1999

New antiinflammatory/immunomodulatory compounds from Signal act at a transcriptional level

Feb. 12, 1999

Neurogen and Pfizer collaborate on development of NPY receptor ligands

Feb. 12, 1999

Astra describes N-type neuronal calcium channel blockers and their use

Feb. 12, 1999

Orally bioavailable tachykinin antagonists from MS&D for emesis, etc.

Feb. 12, 1999

Antiinflammatory/immunosuppressant agents acting on p38 MAP kinase designed at Novartis

Feb. 11, 1999

Zeneca patents new class of DNA gyrase-inhibiting antibiotics

Feb. 11, 1999

New polycarboxamides with multiple pharmacological actions developed at Pharmacia & Upjohn

Feb. 11, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...